Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial

Analyst Price Targets

Price Target Recent News

Paychex Analysts Cut Their Forecasts After Q3 Results
Paychex Analysts Cut Their Forecasts After Q3 Results
Paychex (NASDAQ:PAYX) reported strong Q3 results, with revenue of $1.81B beating expectations. Analysts maintain neutral ratings with lowered price targets.
Wall Street's Most Accurate Analysts Give Their Take On 3 Defensive Stocks With Over 7% Dividend Yields
Wall Street's Most Accurate Analysts Give Their Take On 3 Defensive Stocks With Over 7% Dividend Yields
In uncertain markets, investors turn to dividend-yielding stocks. Analysts' ratings and accuracy can be found on Benzinga's website.
Arm Holdings To Rally Over 27%? Here Are 10 Top Analyst Forecasts For Thursday
Arm Holdings To Rally Over 27%? Here Are 10 Top Analyst Forecasts For Thursday
Wall Street analysts change ratings on top stocks: BNP Paribas cuts Chewy Inc, Bernstein cuts Qualcomm, Wells Fargo raises United Natural Foods.
Oxford Industries Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Oxford Industries Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Oxford Industries (NYSE: OXM) will release Q4 earnings on March 26. Analysts expect earnings of 3 cents/share and revenue of $371.84M.
These Analysts Revise Their Forecasts On Braze Following Q4 Results
These Analysts Revise Their Forecasts On Braze Following Q4 Results
Braze (BRZE) beats Q4 revenue estimates and announces $100 million share buyback. Analysts have mixed ratings and price targets for the stock.
TELA Bio Analysts Cut Their Forecasts After Q4 Results
TELA Bio Analysts Cut Their Forecasts After Q4 Results
TELA Bio (NASDAQ:TELA) reported mixed Q4 results, with higher losses but lower sales than expected. Analysts lowered price targets for the stock.
KB Home Analysts Lower Their Forecasts After Downbeat Q1 Results
KB Home Analysts Lower Their Forecasts After Downbeat Q1 Results
KB Home (NYSE:KBH) reported weak Q1 results, missing earnings and revenue estimates. Analysts have lowered price targets for the stock.
These Analysts Cut Their Forecasts On Concentrix Following Q1 Results
These Analysts Cut Their Forecasts On Concentrix Following Q1 Results
Concentrix Corp (NASDAQ: CNXC) reported mixed Q1 results and issued lower Q2 guidance. Analysts lowered their price targets. Stock fell 6.9%.
Core & Main Analysts Slash Their Forecasts After Q4 Results
Core & Main Analysts Slash Their Forecasts After Q4 Results
Core & Main (NYSE:CNM) reported mixed Q4 results, with adjusted EPS of 52 cents and sales of $1.581 billion. FY2026 sales estimated at $7.8-$7.9 billion.
Jefferies Financial Likely To Report Higher Q1 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Jefferies Financial Likely To Report Higher Q1 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Jefferies Financial Group Inc. (NYSE: JEF) to release Q1 earnings on 3/25. Analysts expect EPS of $0.91 and revenue of $1.98B. SMFG not currently planning takeover bid. JEF shares down 1.7% at $39.88. Analysts rate JEF as Market Perform, Outperform, and Buy with accuracy rates of 67%, 81%, and 56% respectively.
Arm's New AGI CPU Turns It From Licensing Story Into A Chip Seller—With Meta As The First Big Test
Arm's New AGI CPU Turns It From Licensing Story Into A Chip Seller—With Meta As The First Big Test
Arm Holdings (ARM) debuts AGI CPU, BofA sees TAM up 40x to $100B FY27 from $2.4B royalties, Meta lead customer. PT $155, Neutral. Chip rev $1B FY27-28.
Ondas Reloads With $1.5B Cash, Aggressive Deals And 100%+ Upside Target
Ondas Reloads With $1.5B Cash, Aggressive Deals And 100%+ Upside Target
Ondas delivered record quarterly results, sharply boosting its 2026 outlook and winning an analyst price-target hike.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved